Example: Correcting a 409A Before It Spooked the Option Pool
A B2B cybersecurity SaaS company's 409A valuation was coming in well above what its Series A preferred price implied, a gap that risked confusing new hires and the board alike. Coordinating the 409A process directly closed the gap with a defensible narrative instead of a lucky number.
The company's outside 409A provider returned a common-share valuation uncomfortably close to its Series A preferred price from eighteen months earlier, a result that made little sense given that preferred shares carry liquidation preferences and other rights common stock does not, and would have made every new employee's option grant look artificially expensive relative to what a comparable pre-Series-A hire had received. The board noticed the mismatch within a day of seeing the draft, and questions started about whether the whole valuation process could be trusted.
The 409A provider's methodology was reviewed directly, revealing that the comparable-company set skewed toward larger, later-stage security vendors with materially higher growth and margin profiles than the company's actual stage. The provider was engaged to correct the peer set to companies genuinely comparable on revenue scale and growth rate, and a one-page valuation memo was built connecting the corrected 409A, the Series A preferred price, and the company's real growth trajectory into one consistent, board-ready narrative.
Corrected 409A valuation came in 34% lower and aligned with the Series A preferred price band, preserving the option pool's intended value for the next two full hiring cycles
A 409A that comes in higher than expected can sound like good news for about a day, until someone actually works through what it does to the option pool and to the board’s confidence in the number behind it.
Background
The company had raised a Series A round about eighteen months earlier and was growing steadily, hiring roughly a dozen new employees a quarter across engineering and go-to-market. Every one of those hires received an option grant priced at the company’s most recent 409A common-share fair market value, which meant the accuracy of that number mattered directly to dozens of individual compensation packages, not just to an abstract line item in a board deck.
A valuation that didn’t match the story
The outside 409A provider returned a common-share valuation uncomfortably close to the Series A preferred price, a gap that should ordinarily be significantly wider given that preferred shares carry liquidation preferences, anti-dilution protection, and other rights that plain common stock does not. The board noticed the mismatch within a day of seeing the draft report, and the reaction was immediate concern rather than reassurance: if the 409A had drifted this far from what everyone understood the company’s actual value progression to be, what else in the finance function’s numbers might be off.
Finding the actual cause, not just accepting the uncomfortable number
Rather than treating the valuation as a fixed output to simply work around, the 409A provider’s methodology was reviewed directly, line by line, against the assumptions it relied on. The real issue turned out to be the comparable-company set: it skewed toward larger, later-stage security vendors with meaningfully higher revenue, growth rates, and margin profiles than the company’s actual stage warranted. That skew pulled the implied revenue multiple, and with it the entire valuation, upward in a way that had nothing to do with the company’s own performance.
Correcting the peer set and building the narrative
The 409A provider was engaged directly to correct the comparable set to companies genuinely similar in stage, revenue scale, and growth rate, a legitimate and fairly common methodology adjustment rather than a request to simply hit a preferred number. Once the corrected valuation came back, a one-page memo was built connecting the corrected 409A, the Series A preferred price, and the company’s actual growth trajectory into a single, internally consistent story, the kind a board member could repeat confidently and accurately to a future investor without having to caveat it.
Why this kind of gap is more common than founders expect
409A providers work from standardized comparable-company databases and valuation models that are not always recalibrated carefully for every individual client’s specific stage and growth profile, especially at firms handling a high volume of reports on tight turnaround times. A comparable set that made sense for a client three tiers ahead in revenue can get reused, sometimes without a full re-screen, for a company at an earlier stage in the same broad sector. Catching that kind of drift requires someone reviewing the methodology itself, not just the headline number.
Results
The corrected 409A valuation came in 34% lower and back in line with the Series A preferred price band, preserving the option pool’s intended value for the next two full hiring cycles and giving the board a valuation story that actually held together under scrutiny.
Questions
FAQ
Isn't the 409A supposed to be independent of company influence?
Yes, and it stayed that way throughout this process. The request made to the provider was never to hit a target number; it was to review whether the comparable-company set they had used actually matched the company's revenue stage and growth profile, which is a legitimate, standard methodology question that any competent 409A provider should welcome. The distinction matters both practically and legally: a valuation firm that adjusts its number because a client asked for a specific figure has compromised the independence that makes a 409A defensible in an IRS audit, while a valuation firm that corrects a comparable set in response to a substantive methodology question has simply done its job more carefully.
Why does the gap between 409A and preferred price matter so much in practice?
A common-share valuation that sits too close to the preferred price makes every new option grant meaningfully more expensive for the employee relative to its real economic value, since the strike price is set at the 409A fair market value and a higher strike price means less potential upside baked into the same number of shares. Beyond the immediate hiring impact, a board that notices the mismatch late tends to start asking harder, more skeptical questions about the entire valuation process going forward, which slows down every future 409A refresh and erodes the trust that makes routine governance efficient.
How often should a company revisit its 409A this closely, rather than just accepting the provider's number?
At minimum with every new priced funding round or after twelve months, whichever comes first, and sooner than that if the company has a material change in revenue model, growth rate, or if comparable public or private companies in its sector have moved meaningfully in valuation. A quick sanity check against the company's own preferred price and growth trajectory, done by someone who actually understands both the 409A methodology and the company's cap table, catches most of these gaps before they reach the board in a form that damages confidence.
Working on something similar?
Tell us about your stage and what's next.